Sensitivity of the Home Macular Perimeter (HMP)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

99 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-11-30

Study Completion Date

2008-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

estimate the sensitivity of the HMP test in identifying visual field functional defects in subjects with CNV secondary to AMD

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sensitivity and Specificity of the Home Macular Perimeter (HMP)

NCT00595998

Age Related Macular Degeneration

COMPLETED

Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP)

NCT00603850

Age Related Macular Degeneration

COMPLETED

Usage of the Home Macular Perimeter (HMP)

NCT00596388

Age Related Macular Degeneration

COMPLETED

HMP (Home Macular Perimeter) -Usability Trial

NCT00592826

Age Related Macular Degeneration

COMPLETED

Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.

NCT04650672

Retinal Neovascularization

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The HMP device is intended to aid patients in identifying their visual abnormalities and in addition to their own symptoms or Amsler grid use and aid in their prompt referral to eye care professional examination so clinical diagnosis can be made. As such the goal of the clinical plan is to demonstrate that patients who have CNV do demonstrate visual field abnormalities when tested with the HMP

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Age Related Macular Degeneration Choroidal Neovascularization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

subjects with AMD related lesions: New onset (up to 60 days) non-treated CNV

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Capable and willing to sign a consent form and participate in the study
* subjects with AMD related lesions: New onset (up to 60 days) non-treated CNV
* Age \>50 years
* VA with habitual correction \>20/200 in study eye
* Familiar with computer usage

Exclusion Criteria

* Evidence of macular disease other than AMD or glaucoma in the study eye
* Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy, CFP, or FA
* Any non-macular related ocular surgery performed within 3 months prior to study entry in the targeted eye
* Inability to tolerate intravenous FA
* Participation in another study with the exclusion of AREDS study

Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No